© 2020 MJH Life Sciences and Patient Care Online. All rights reserved.
FDA Fast Track designation is to investigate whether the diabetes medication can also reduce kidney disease progression.
Cardiovascular diseases, particularly heart failure, were found significantly and independently associated with end-stage renal disease in a new analysis.
New risk prediction models may help identify patients with and without diabetes at elevated risk for chronic kidney disease, say authors of a recent study.